Molecular Diagnostics Market in Good Shape in 2020; COVID-19 to Affect Future Growth Trajectory | Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH

According to the current analysis of Reports and Data, the global Molecular Diagnostics market was valued at USD 7.28 Billion in 2018 and is expected to reach USD 13.81 Billion by year 2026, at a CAGR of 8.2%. The increasing efficiency of clinical trials, growing incidence of infectious and neurological diseases, and technological advancements in molecular pathology are major driving factors being the growth of the market. The increasing government aid for research and establishment of advanced testing facilities is also supporting the growth of the market.

This is the latest report that is inclusive of the current effect of the coronavirus on the market and its forecasted trend. The coronavirus attack on the world economy has impacted all, and thus its impacts are elucidated in-depth in the report for the Molecular Diagnostics market.

Free Sample Report + All Related Graphs & Charts @ https://www.reportsanddata.com/sample-enquiry-form/945

Some of the dominant and influential players in the Molecular Diagnostics market are:

Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, Bio-Rad Laboratories, Dickinson and Co., Cepheid

The research helps the user to better comprehend the historical background of the Molecular Diagnostics market based on facts and figures. The various aspects and factors also include the cost of the products that gather a relatively higher demand and their production cost for the producer to determine the optimum strategy to produce.

The Global Molecular Diagnostics Market is expected to reach the valuation of USD 116.8 billion by the year 2026, growing at a CAGR of nearly 4.7% through the years.

Key highlights of the Molecular Diagnostics Reports:

The report encompasses segmentation and market information break down, including key participants. If you are involved in the Global Molecular Diagnostics industry or aspire to be involved, this report is a must-have. The report makes an in-depth study on the market share, growth rate, market drivers, future trends, restraints, opportunities, and challenges.

For the purpose of this report, Reports and Data has segmented the Molecular Diagnostics market on the basis of product and service, technology, application, end use, and region:

Product and Service (Revenue, USD Million; 2016-2026)
Reagents and Kits
Instruments
Services and Software

Technology (Revenue, USD Million; 2016-2026)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing & Next-Generation Sequencing (NGS)
in Situ Hybridization
DNA Microarray
Other Technologies

Application (Revenue, USD Million; 2016-2026)
Infectious Diseases
Hepatitis
HIV
CT/NG
HAIS
HPV
Tuberculosis
Influenza
Other Infectious Diseases
Oncology
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Other Cancers
Genetic Tests
Others

Supermarkets Get Discount on the Report @ https://www.reportsanddata.com/discount-enquiry-form/945

End Use (Revenue, USD Million; 2016-2026)
Hospital and Academic Laboratories
Reference Laboratories
Others

Furthermore, the years considered for the study are as follows:
Historical year - 2016-2018
Base year - 2019
Forecast period - 2020 to 2027

Further key findings from the report suggest-

-The Veterinary Molecular Diagnostics market is witnessing a blooming growth as fungicidal therapies are being increasingly developed. Moreover, the development of specific assays and reagents has also contributed to the growth of the market.

-Based on product and service type, the reagents and kits segment held the largest share in the market in base year 2018. The increasing ease of usage and a widening applicability of reagents and kits is boosting market growth.

-Based on technology, the Polymerase Chain Reaction (PCR) segment held the largest share in the global Molecular Diagnostics market. The penetration of technological advancements in medical science along with the growing automation of PCR instruments contributes to this share.

-By application, infectious diseases form the largest segment as they make the maximum usage of Molecular Diagnostics for diagnosis and therapeutic purposes. The incidence of infectious diseases has been increasing and government support is strong to eradicate their spread.

-The oncology segment, by application, is expected to register the highest CAGR during the period of forecast. The colorectal cancer molecular diagnostics, in particular, has been registering an impressive rate of growth during the forecast period.

-The instruments segment is expected to register a high CAGR during the forecast period. The demand for instruments is mainly driven by testing laboratories and clinics.

Key points discussed in the report for Global Molecular Diagnostics Market:

Chapter 1: Introduction, market driving force product, Objectives of the Study, and Research Scope of the Molecular Diagnostics market.

Chapter 2: Exclusive Summary -vital information of the Molecular Diagnostics Market.

Chapter 3: Market Dynamics- Drivers, Trends, and Challenges of the Molecular Diagnostics Market.

Chapter 4: Molecular Diagnostics Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Market segmentation by Type, End-User and Region 2016-2018.

Chapter 6: Analysis of the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Chapter 7 & 8: Appendix, Methodology and Data Source...Continued

Finally, Molecular Diagnostics Market is a valuable source of guidance for individuals and companies.

Access Full Report details @ https://www.reportsanddata.com/report-detail/global-molecular-diagnostics-market

Contact Us:

John Watson
Head of Business Development
Address: 40 Wall St. 28th floor New York City, USA
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.